Paul Baldrick

2.1k total citations · 1 hit paper
59 papers, 1.5k citations indexed

About

Paul Baldrick is a scholar working on Small Animals, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Paul Baldrick has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Small Animals, 18 papers in Immunology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Paul Baldrick's work include Animal testing and alternatives (18 papers), Immunotoxicology and immune responses (10 papers) and Biosimilars and Bioanalytical Methods (9 papers). Paul Baldrick is often cited by papers focused on Animal testing and alternatives (18 papers), Immunotoxicology and immune responses (10 papers) and Biosimilars and Bioanalytical Methods (9 papers). Paul Baldrick collaborates with scholars based in United Kingdom, United States and Netherlands. Paul Baldrick's co-authors include A.W. Wheeler, Lesley Reeve, Paul Hepburn, J.H. Anstee, Gary Elliott, Linda J. Lea, Alison Wolfreys, Stefan R. Woroniecki, David Hyde and Kathryn Chapman and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Food and Chemical Toxicology and Vaccine.

In The Last Decade

Paul Baldrick

57 papers receiving 1.4k citations

Hit Papers

The safety of chitosan as a pharmaceutical excipient 2009 2026 2014 2020 2009 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The safety of chitosan as a pharmaceutical excipient
    2009 443 citations Paul Baldrick Regulatory Toxicology and Pharmacology profile →

Peers

Paul Baldrick
Silvya Stuchi Maria–Engler Brazil
Günther Weindl Germany
Eric R. Gremmer Netherlands
Yolanda Gilaberte Spain
R. Randall Wickett United States
Elisabetta Buommino Italy
August Bernd Germany
Elma D. Baron United States
Laura de Oliveira Nascimento Brazil
Michael K. Robinson United States
Silvya Stuchi Maria–Engler Brazil
Paul Baldrick
Citations per year, relative to Paul Baldrick Paul Baldrick (= 1×) peers Silvya Stuchi Maria–Engler

Countries citing papers authored by Paul Baldrick

Since Specialization
Citations

This map shows the geographic impact of Paul Baldrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Baldrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Baldrick more than expected).

Fields of papers citing papers by Paul Baldrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Baldrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Baldrick. The network helps show where Paul Baldrick may publish in the future.

Co-authorship network of co-authors of Paul Baldrick

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Baldrick. A scholar is included among the top collaborators of Paul Baldrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Baldrick. Paul Baldrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Passini, Elisa, Adeyemi O. Adedeji, Rich Allen, et al.. (2025). Applying the 3Rs to urinalysis assessments in toxicity studies: refining procedures and adopting a case-by-case approach. Comparative Clinical Pathology. 34(2). 311–322.
2.
Baldrick, Paul & Sanjay K. Jain. (2023). Carcinogenicity testing in drug development: Getting it right. Regulatory Toxicology and Pharmacology. 145. 105522–105522. 5 indexed citations
3.
Baldrick, Paul. (2022). Successful regulatory agency interaction – A nonclinical regulatory strategist's perspective. Regulatory Toxicology and Pharmacology. 130. 105130–105130. 2 indexed citations
4.
Baldrick, Paul. (2021). Core battery safety pharmacology testing – An assessment of its utility in early drug development. Journal of Pharmacological and Toxicological Methods. 109. 107055–107055. 7 indexed citations
5.
Baldrick, Paul. (2018). Juvenile Animal Testing: Assessing Need and Use in the Drug Product Label. Therapeutic Innovation & Regulatory Science. 52(5). 641–648. 8 indexed citations
6.
Baldrick, Paul. (2017). Getting a molecule into the clinic: Nonclinical testing and starting dose considerations. Regulatory Toxicology and Pharmacology. 89. 95–100. 13 indexed citations
7.
Baldrick, Paul. (2017). Pharmacokinetic and toxicology comparator testing of biosimilar drugs – Assessing need. Regulatory Toxicology and Pharmacology. 86. 386–391. 9 indexed citations
8.
Chapman, Kathryn, Paul Baldrick, Antônio da Silva, et al.. (2016). Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges. mAbs. 8(3). 427–435. 28 indexed citations
9.
Baldrick, Paul & Lesley Reeve. (2015). Risk Management Plans in the European Union: Nonclinical Aspects. Therapeutic Innovation & Regulatory Science. 50(1). 101–105. 2 indexed citations
10.
Baldrick, Paul. (2014). Utility and importance of animal data in drug product labels. Regulatory Toxicology and Pharmacology. 69(3). 546–557. 6 indexed citations
11.
12.
Baldrick, Paul. (2010). Safety evaluation of biological drugs: What are toxicology studies in primates telling us?. Regulatory Toxicology and Pharmacology. 59(2). 227–236. 30 indexed citations
13.
Baldrick, Paul. (2010). Juvenile animal testing in drug development – Is it useful?. Regulatory Toxicology and Pharmacology. 57(2-3). 291–299. 32 indexed citations
14.
Baldrick, Paul. (2009). The safety of chitosan as a pharmaceutical excipient. Regulatory Toxicology and Pharmacology. 56(3). 290–299. 443 indexed citations breakdown →
15.
Baldrick, Paul. (2005). Carcinogenicity Evaluation: Comparison of Tumor Data from Dual Control Groups in the Sprague–Dawley Rat. Toxicologic Pathology. 33(2). 283–291. 30 indexed citations
16.
Baldrick, Paul, et al.. (2004). Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy. Journal of Applied Toxicology. 24(4). 261–268. 16 indexed citations
17.
Baldrick, Paul, et al.. (2002). Review of L‐tyrosine confirming its safe human use as an adjuvant. Journal of Applied Toxicology. 22(5). 333–344. 60 indexed citations
18.
Carthew, P., Paul Baldrick, & Paul Hepburn. (2001). An assessment of the carcinogenic potential of shea oleine in the rat. Food and Chemical Toxicology. 39(8). 807–815. 8 indexed citations
19.
Baldrick, Paul, et al.. (2001). Reproduction studies in the rat with shea oleine and hardened shea oleine. Food and Chemical Toxicology. 39(9). 923–930. 5 indexed citations
20.
Baldrick, Paul, et al.. (1997). A toxicological review of lactose to support clinical administration by inhalation. Food and Chemical Toxicology. 35(7). 719–733. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvya Stuchi Maria–Engler Breakdown of academic impact, for papers by Günther Weindl Breakdown of academic impact, for papers by Eric R. Gremmer Breakdown of academic impact, for papers by Yolanda Gilaberte Breakdown of academic impact, for papers by R. Randall Wickett Breakdown of academic impact, for papers by Elisabetta Buommino Breakdown of academic impact, for papers by August Bernd Breakdown of academic impact, for papers by Elma D. Baron Breakdown of academic impact, for papers by Laura de Oliveira Nascimento Breakdown of academic impact, for papers by Michael K. Robinson
Rankless by CCL
2026